A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues

Molecular and Cellular Proteomics

Volumn 13, Issue 4, 2014, Pages 1065-1075

  Xiao, Yongsheng ^a   Guo, Lei ^a   Wang, Yinsheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; DASATINIB; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; ENZYME BINDING; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEOMICS;

ADENOSINE TRIPHOSPHATE; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; HELA CELLS; HUMANS; ISOTOPE LABELING; LUNG NEOPLASMS; MASS SPECTROMETRY; MELANOMA; MOLECULAR PROBES; PHOSPHOTRANSFERASES; PROTEIN KINASE INHIBITORS; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 84898751411     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.036905     Document Type: Article

References (34)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934
2. Blume-Jensen, P., and Hunter, T. (2001) Oncogenic kinase signalling. Nature 411, 355-365
3. Duncan, James S., Whittle, Martin C., Nakamura, K., Abell, Amy N., Midland, Alicia A., Zawistowski, Jon S., Johnson, Nancy L., Granger, Deborah A., Jordan, Nicole V., Darr, David B., Usary, J., Kuan, P.-F., Smalley, David M., Major, B., He, X., Hoadley, Katherine A., Zhou, B., Sharpless, Norman E., Perou, Charles M., Kim, William Y., Gomez, Shawn M., Chen, X., Jin, J., Frye, Stephen V., Earp, H. S., Graves, Lee M., and Johnson, Gary L. (2012) Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell 149, 307-321
4. Zhang, J., Yang, P. L., and Gray, N. S. (2009) Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer 9, 28-39
5. Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., Faraoni, R., Floyd, M., Hunt, J. P., Lockhart, D. J., Milanov, Z. V., Morrison, M. J., Pallares, G., Patel, H. K., Pritchard, S., Wodicka, L. M., and Zarrinkar, P. P. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat. Biotech. 26, 127-132
6. Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., Ford, J. M., Galvin, M., Gerlach, J. L., Grotzfeld, R. M., Herrgard, S., Insko, D. E., Insko, M. A., Lai, A. G., Lelias, J.-M., Mehta, S. A., Milanov, Z. V., Velasco, A. M., Wodicka, L. M., Patel, H. K., Zarrinkar, P. P., and Lockhart, D. J. (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotech. 23, 329-336
7. Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., and Zarrinkar, P. P. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotech. 29, 1046-1051
8. Pulford, K., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., and Mason, D. Y. (1997) Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89, 1394-1404
9. Cox, J., and Mann, M. (2011) Quantitative, high-resolution proteomics for data-driven systems biology. Annu. Rev. Biochem. 80, 273-299
10. Oppermann, F. S., Gnad, F., Olsen, J. V., Hornberger, R., Mann, M., and Daub, H. (2009) Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 8, 1751-1764
11. Marx, V. (2013) Targeted proteomics. Nat. Meth. 10, 19-22
12. Daub, H., Olsen, J. V., Bairlein, M., Gnad, F., Oppermann, F. S., Stemmann, O., and Mann, M. (2008) Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell. 31, 438-448
13. Villamor, J. G., Kaschani, F., Colby, T., Oeljeklaus, J., Zhao, D., Kaiser, M., Patricelli, M. P., and van der Hoorn, R. A. L. (2013) Profiling protein kinases and other ATP binding proteins in arabidopsis using Acyl-ATP Probes. Mol. Cell. Proteomics 12, 2481-2496
14. Ansong, C., Ortega, C., Payne, Samuel H., Haft, Daniel H., Chauvigne-Hines, Lacie M., Lewis, Michael P., Ollodart, Anja R., Purvine, Samuel O., Shukla, Anil K., Fortuin, S., Smith, Richard D., Adkins, Joshua N., Grundner, C., and Wright, Aaron T. (2013) Identification of widespread adenosine nucleotide binding in mycobacterium tuberculosis. Chem. Biol. 20, 123-133
15. Xiao, Y., Guo, L., Jiang, X., and Wang, Y. (2013) Proteome-wide discovery and characterizations of nucleotide-binding proteins with affinity-labeled chemical probes. Anal. Chem. 85, 3198-3206
16. Patricelli, M. P., Szardenings, A. K., Liyanage, M., Nomanbhoy, T. K., Wu, M., Weissig, H., Aban, A., Chun, D., Tanner, S., and Kozarich, J. W. Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 46, 350-358
17. Patricelli, Matthew P., Nomanbhoy, Tyzoon K., Wu, J., Brown, H., Zhou, D., Zhang, J., Jagannathan, S., Aban, A., Okerberg, E., Herring, C., Nordin, B., Weissig, H., Yang, Q., Lee, J.-D., Gray, Nathanael S., and Kozarich, John W. (2011) In situ kinase profiling reveals functionally relevant properties of native kinases. Chem. Biol. 18, 699-710
18. Olsen, J. V., Schwartz, J. C., Griep-Raming, J., Nielsen, M. L., Damoc, E., Denisov, E., Lange, O., Remes, P., Taylor, D., Splendore, M., Wouters, E. R., Senko, M., Makarov, A., Mann, M., and Horning, S. (2009) A dual pressure linear ion trap orbitrap instrument with very high sequencing speed. Mol. Cell. Proteomics 8, 2759-2769
19. Picotti, P., and Aebersold, R. (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Meth. 9, 555-566
20. Lange, V., Picotti, P., Domon, B., and Aebersold, R. (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol., 222
21. Xiao, Y., Guo, L., and Wang, Y. (2013) Isotope-coded ATP probe for quantitative affinity profiling of ATP-binding proteins. Anal. Chem. 85, 7478-7486
22. Escher, C., Reiter, L., MacLean, B., Ossola, R., Herzog, F., Chilton, J., MacCoss, M. J., and Rinner, O. (2012) Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111-1121
23. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., and MacCoss, M. J. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968
24. Abbatiello, S. E., Mani, D. R., Keshishian, H., and Carr, S. A. (2010) Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin. Chem. 56, 291-305
25. James, L. C., and Tawfik, D. S. (2003) The specificity of cross-reactivity: Promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness. Protein. Sci. 12, 2183-2193
26. Westermark, B., Johnsson, A., Paulsson, Y., Betsholtz, C., Heldin, C. H., Herlyn, M., Rodeck, U., and Koprowski, H. (1986) Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGFlike growth factor. Proc. Natl. Acad. Sci. U.S.A. 83, 7197-7200
27. Eustace, A. J., Dowling, P., Henry, M., Doolan, P., Meleady, P., Clynes, M., Crown, J., and O'Donovan, N. (2011) 2D-DIGE analysis of phosphoenriched fractions from dasatinib-treated melanoma cell lines. J. Proteomics 74, 490-501
28. Senderowicz, A. (1999) Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Invest. New Drugs 17, 313-320
29. Mann, M. (2006) Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7, 952-958
30. Bauer, M., Baumann, J., and Trommer, W. E. (1992) ATP binding to bovine serum albumin. FEBS Lett. 313, 288-290
31. Costello, A. J. R., Marshall, W. E., Omachi, A., and Henderson, T. O. (1977) ATP binding to human hemoglobin in the presence and absence of magnesium ions investigated with 31P NMR spectroscopy and ultrafiltration. Biochim. Biophys. Acta 491, 469-472
32. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., and Carr, S. A. (2007) Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6, 2212-2229
33. Chene, P. (2002) ATPases as drug targets: learning from their structure. Nat. Rev. Drug Discov. 1, 665-673
34. Garman, K. S., Nevins, J. R., and Potti, A. (2007) Genomic strategies for personalized cancer therapy. Hum. Mol. Genet. 16, R226-R232